Historical review: endothelin
T Masaki - Trends in Pharmacological Sciences, 2004 - cell.com
Endothelin (ET) is a potent vasoconstrictive peptide that was isolated initially from the
conditioned medium of cultured endothelial cells. In 1988, details of the isolation and …
conditioned medium of cultured endothelial cells. In 1988, details of the isolation and …
The endothelin family: an overview
T Masaki - Journal of cardiovascular pharmacology, 2000 - journals.lww.com
Endothelin (ET) is a potent vasoconstrictive peptide initially found in the conditioned medium
of cultured endothelial cells (1). It comprises 21 amino acid residues including four cysteine …
of cultured endothelial cells (1). It comprises 21 amino acid residues including four cysteine …
The endothelin system and its potential as a therapeutic target in cardiovascular disease
Endothelin (ET)-1, an endothelium-derived peptide, is the most potent vasoconstrictor agent
described to date. ET-1 also has positive inotropic and chronotropic effects in the heart and …
described to date. ET-1 also has positive inotropic and chronotropic effects in the heart and …
Endothelin‐1 and the regulation of vascular tone
M La, JJ Reid - Clinical and experimental pharmacology and …, 1995 - Wiley Online Library
In 1988, Yanagisawa et al. reported the presence of a potent peptide from the supernatant of
porcine endothelial cells. This was later named endothelin‐1 (ET‐1) and was found to …
porcine endothelial cells. This was later named endothelin‐1 (ET‐1) and was found to …
The discovery, the present state, and the future prospects of endothelin
T Masaki - Journal of Cardiovascular Pharmacology, 1989 - journals.lww.com
Endothelin-1 (ET-1) is a potent vasoconstrictive peptide produced by endothelial cells of
blood vessels. This peptide has quite a unique structure and pharmacological properties. ET …
blood vessels. This peptide has quite a unique structure and pharmacological properties. ET …
Molecular pharmacology and pathophysiological significance of endothelin
K Goto, H Hama, Y Kasuya - The Japanese Journal of Pharmacology, 1996 - jstage.jst.go.jp
Since the discovery of the most potent vasoconstrictor peptide, endothelin, in 1988,
explosive investigations have rapidly clarified much of the basic pharmacological …
explosive investigations have rapidly clarified much of the basic pharmacological …
[HTML][HTML] Secretory pathways in endothelin synthesis
FD Russell, AP Davenport - British journal of pharmacology, 1999 - ncbi.nlm.nih.gov
Endothelin (ET) is a potent vasoconstrictor peptide that is generated via unique processing
of a low activity precursor, big ET-1 by endothelin converting enzymes (ECEs). ET has a …
of a low activity precursor, big ET-1 by endothelin converting enzymes (ECEs). ET has a …
Molecular and cellular biology of endothelin and its receptors
TF Lüscher, BS Oemar, CM Boulanger… - Molecular Reviews in …, 1996 - Springer
Abstract The endothelins (ET) are 21-amino-acid peptides produced by endothelial cells
and many other tissues [1]. Three isoforms of ET have been characterized (ET-1, 2 and 3) …
and many other tissues [1]. Three isoforms of ET have been characterized (ET-1, 2 and 3) …
Endothelin and endothelin antagonists: pharmacology and clinical implications.
TF Lüscher, RR Wenzel - Agents and actions. Supplements, 1995 - europepmc.org
Endothelins (ET) are a family of peptides with potent biological properties. Endothelial cells
produce exclusively ET-1 while other tissues produce ET-2 and ET-3. The production of ET …
produce exclusively ET-1 while other tissues produce ET-2 and ET-3. The production of ET …
[引用][C] Endothelin receptors cloned, endothelin converting enzyme characterized and pathophysiological roles for endothelin proposed
DJ Webb - Trends in Pharmacological Sciences, 1991 - Elsevier
In 1988, Yanagisawa and colleagues' isolated from the culture medium of vascular
endothelial cells a novel 21 amino-acid pep tide, endothelln, which is the most potent …
endothelial cells a novel 21 amino-acid pep tide, endothelln, which is the most potent …